1.The rate of p53 gene carrier in the high risk group of exposure to dioxine
Journal of Medical Research 2005;38(5):15-16
Diseases caused by dioxine include mainly various types of cancers and p53 is one important gene in carcinogenesis-suppressing gene family. Objectives: This research's goal is detecting p53 gene's ratio in the high risk group of exposure to dioxine. Methods: In this study we detected p53 ratio in 50 cases in the group of high risk of exposure to dioxine and the control group of 30 cases. Gene p53 was detected by PCR technique. Results: The study showed that in the control group (no exposure to dioxine), p53 prevalence is 100% compared with 82% in high - risk group (p <0.05). Conclusions: p53 was not detected in 18% of the group of high risk exposure to dioxin, suggesting that there were serious damages in p53 gene (deletion...)
Genes, p53
2.Comparison of class switch recombination assays for immunoglobulin synthesis
Journal of Medical Research 2005;39(6):5-9
The second step of immunoglobulin gene alteration consists of somatic hypermutation and class switch recombination. 80th are regulated by activation-induced cytidine deaminase (AID). Methods: Study on possible application of class switch recombination assays for immunoglobulin gene alteration via AID. Cell based assays using AID B lymphocyte and NIH3T3 cell carrying switch substrate; gene transfer using retrovirus system; FACS analysis; PCR and ELISA. Results: DNA sequencing for S region and gamma1CT are the most sensitive and accurate assays. However, gamma1CT assay seemed to be more reliable and applicable. Others are accurate assays but less applicable. Conclusion: gamma1CT determination is the best class switch recombination assay for immunoglobulin gene alteration via AID.
Immunoglobulins, Genes
3.Cancer Gene Therapy.
Journal of the Korean Medical Association 1998;41(8):836-840
No abstract available.
Genes, Neoplasm*
4.Cancer Gene Therapy: Limitations and Progress.
Cancer Research and Treatment 2003;35(3):175-176
No abstract available.
Genes, Neoplasm*
5.Analysis of genetic characteristics of two families having two children with Down's syndrome
Journal of Medical Research 2005;34(2):5-11
. Genetic characteristics of two families having two children with Down's syndrome were analysed in the Department of Medical Biology and Genetics - Hanoi Medical University. Results: Family 1: Couple have two sons with Down's syndrome trisomy 21. Karyotype of the father 46,XY. Karyotype of the mother 46,XY Two sons (5 years and 3 years of old) have karyotype 47,XY,+21. Two sons have single horizontal fold on both hands. Family 2: Couple have a girl and a son with Down's syndrome translocated chromosome t (13;21). Karyotype of the father: 46,XY and of the mother 45,XX,-13,+t(13;21). Karyotype of the girl (12 years): 46,XX, 13,+t(13;21). Karyotype of the son (7 years) have: 46,XY,-13, +t(13;21). Two children have not any single fold on the hands.
Down Syndrome, Child, Genes
6.Cloning of the gene encoding human interleukin-2
Journal of Vietnamese Medicine 2005;310(5):26-30
Study on cloning of the gene encoding human interleukin-2 with gene produce method by RT-PCR. Results: cloned and determine order of gene fragment encoded IL-2 that having 333pp size (133 amino acids) from total RNA of human spleen by RT-PCR. The results of analysis order of cloned IL2 gem showed that there were 2 changes of single nucleotide (A36G, G54T) in comparison with that of the NP-000577 order registered in NCBI GenBank A36G and G54T. However, these changes did not make changes in amino acid sequence of the cloned II-2 gene
Interleukins
;
Human
;
Genes
7.Investigation of point mutations in pbp1a gene of streptococcus pneumoniae resistant strains by PCR-SSCP-sequencing
Journal Ho Chi Minh Medical 2004;8(2):103-107
Study used the methods of PCR-SSCP-sequencing to detect and identify point mutations in pbp1a gene, one of the genes involved in penicillin resistance of streptococcus pneuminiae. SSCP analysis result of PCR products from 19 clinical resistant and 1 susceptible strains allowed their classification into defferent groups depending on their electrophoretic pattern. This classification fits results obtained by sequencing. With improvement in the resolution capacity of SSCP, these methods could be used efficiently to investigate penicillin resistance in streptococcus pneuminiae
Streptococcus pneumoniae
;
Mutation
;
Genes
8.The prevalence and deleted mutations of LMP1-EVB gene UCNT-NPC patients
Journal of Medical Research 2003;23(3):90-97
The study was performed on 20 couples samples of nasopharyngeal carcinoma patients in K hospital in Hanoi. The findings indicated that: the prevalence of LMP1-EBV gene in peripheral blood of healthy persons was 96.7% (29/30 positive cases); the prevalence of LMP1-EBV gene in 20 UCNT nasopharyngeal carcinoma patients was 100% (20/20 positive cases); the prevalence of LMP1-EBV gene in 20 patients with other head and neck tumors was 100% (5/5 positive cases). On electrophoresis, 90% biopsies of nasopharyngeal carcinoma patients had deletion in LMP1 gene, while LMP1-EBV gene in peripheral blood of these patients, there were only 10% having deletion mutations.
Neoplasms
;
diagnosis
;
Mutation
;
Genes
;
9.Multiplex PCR and detection of three genes of Helicobacter pylori
Journal of Medical Research 2003;0(2):1-4
Bacterium Helicobacter pylori is the causative agent of many gastric disorders. That is why, its correct detection is necessary. However, monitoring the bacteria by amplifying only one gene has used to give false-negative results due to the biodiversity of the bacteria. The conditions for Multiplex PCR amplifying three virulent genes of the bacteria such as cagA., ureaseB and Hp1125 were optimized. It is recommended to detect Helicobacter pylori in clinical setting in Vietnam.
Helicobacter pylori
;
diagnosis
;
Genes
10.Inactivation of gene by small interference RNA
Journal of Medical Research 2003;21(1):89-93
The role of suppression of small RNA molecules in the management of malignity and viral infection on human was studies and discussed. SiRNA (small interference RNA) suppressing gene expression was described. In the year 2001, Ribopharma AG researchers had first demontrated the function of RNAi in mammal cells. SIRPLEX is appropriate with target gene, for using in the treatment of suppression of pathological gene in various genera, including human.
RNA
;
Genes
;
Gene Silencing